Literature DB >> 6420413

Phosphorylation of chondroitin sulfate in proteoglycans from the swarm rat chondrosarcoma.

T R Oegema, E L Kraft, G W Jourdian, T R Van Valen.   

Abstract

Proteoglycans isolated from the Swarm rat chondrosarcoma were shown to contain 35 mol of phosphate/mol of proteoglycan. While 20% of this phosphate was released by digestion with dilute alkali in the presence of sodium borohydride and is presumably of the phosphoserine/phosphothreonine type, 78% of the phosphate copurified with the peptide-free chondroitin sulfate chains. When chondroitin sulfate chains purified by ethanol precipitation or Sephacryl S200 column chromatography were digested with chondroitinase AC and the digests chromatographed on Bio-Gel P-4, the phosphate co-migrated with a carbohydrate fragment that contained 2 glucuronic acid (one as delta 4,5-unsaturated sugar), 1-galactosamine, 2-galactose, and 1-phosphate residue/xylitol. A second fragment of similar composition but lacking phosphate was also recovered in a ratio of about 3 to 1 relative to the phosphorylated fragment. The phosphate in the chondroitin sulfate linkage region fragment had the alkaline phosphatase sensitivity as well as 31P NMR spectra of a monophosphate esterified to a secondary sugar alcohol. The phosphate was localized on the C-2 of the chain initiating xylose since these residues as xylitol showed a delayed release during acid hydrolysis and the xylitol was recovered intact after periodate oxidation. In the chondrosarcoma, 2-phosphoxylose appears to be a normal synthetic product since [32P]phosphate was readily incorporated into the proteoglycan and the incorporated isotope had similar biochemical properties as the unlabeled phosphate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420413

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Difficulties encountered during glycopeptide syntheses.

Authors:  J A Borgia; N B Malkar; H U Abbasi; G B Fields
Journal:  J Biomol Tech       Date:  2001-09

2.  Effects of primer-concentration on uronosyl-epimerization and sulfation patterns in p-hydroxyphenyl-O-beta-D-xylopyranoside-primed galactosaminoglycans produced by skin fibroblasts.

Authors:  F Cheng; B Havsmark; K Sakurai; H Habuchi; S Suzuki; K Yoshida; L A Fransson
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

Review 3.  Proteoglycans in health and disease: structures and functions.

Authors:  A R Poole
Journal:  Biochem J       Date:  1986-05-15       Impact factor: 3.857

Review 4.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

5.  Post-translational processing of chicken bone phosphoproteins. Identification of bone (phospho)protein kinase.

Authors:  Y Mikuni-Takagaki; M J Glimcher
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

6.  Investigating the elusive mechanism of glycosaminoglycan biosynthesis.

Authors:  Xylophone V Victor; Thao K N Nguyen; Manivannan Ethirajan; Vy M Tran; Khiem V Nguyen; Balagurunathan Kuberan
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

7.  Inhibition of heparan sulfate and chondroitin sulfate proteoglycan biosynthesis.

Authors:  Dinesh R Garud; Vy M Tran; Xylophone V Victor; Mamoru Koketsu; Balagurunathan Kuberan
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

8.  Identification of phosphatase that dephosphorylates xylose in the glycosaminoglycan-protein linkage region of proteoglycans.

Authors:  Toshiyasu Koike; Tomomi Izumikawa; Ban Sato; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

9.  Modulation of aggrecan and link-protein synthesis in articular cartilage.

Authors:  A J Curtis; R J Devenish; C J Handley
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

10.  Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.

Authors:  K Lidholt; I Eriksson; L Kjellén
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.